Influence of the Initial Level of Consciousness on Early, Goal-directed Mobilization (SOMS-GCS)

September 11, 2018 updated by: Stefan Schaller, Technical University of Munich
Analysis of the randomized controlled SOMS trial of early, goal-directed mobilization to investigate if the treatment effect is consistent and independent of the initial conscious state without evidence of moderation or modification.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • aged 18 years or older
  • mechanically ventilated for less than 48 h and expected to require mechanical ventilation for at least another 24 h at the time of screening
  • functionally independent at baseline with a Barthel Index Score of at least 70 at 2 weeks before admission to the ICU based on patient or proxy completion of the measure

Exclusion Criteria:

  • admitted to hospital for more than 5 days before screening
  • a motor component of Glasgow Coma Scale (GCS) lower than 5
  • irreversible disorder with a 6-month mortality of greater than 50%,
  • raised intracranial pressure
  • cardiopulmonary arrest
  • unstable fractures contributing to probable immobility
  • inclusion in another trial at the same time
  • acute myocardial infarction
  • do not have lower part of their legs
  • have a rapidly developing neuromuscluar disease
  • pregnant
  • ruptured or leaking aortic aneurysm

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Early, goal-directed mobilization
Early goal-directed mobilization with (1) SOMS algorithm and (2) facilitator
Early, goal directed mobilization using (1) the SOMS algorithm and (2) facilitator
NO_INTERVENTION: Standard of Care
Standard of Care regarding mobilization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional independence at hospital discharge
Time Frame: At the day of hospital discharge, on average up to 1 month
minimal modified functional independence measure score of 8 (Scale ranging from 0-8 with the subdomain locomotion and transfer 0-4 each)
At the day of hospital discharge, on average up to 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
average achieved mobility level during the ICU stay
Time Frame: from ICU admission to ICU discharge, on average up to 2 weeks
mean achieved SOMS level
from ICU admission to ICU discharge, on average up to 2 weeks
Functional status at hospital discharge
Time Frame: At the day of hospital discharge, on average up to 1 month
minimal modified functional independence measure score (range 0-8) of the subdomains transfer and locomotion with 0-4 each
At the day of hospital discharge, on average up to 1 month
Start to mobilization (SOMS > 0)
Time Frame: Days from ICU admission till first mobilization, approximately up to 5 days
Start to mobilization in days (Surgical Optimal Mobilization Scale > 0, ranging from 0 = no mobilization to 4 ambulation)
Days from ICU admission till first mobilization, approximately up to 5 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthias Eikermann, MD, Beth Israel Deaconess Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 11, 2011

Primary Completion (ACTUAL)

November 4, 2015

Study Completion (ACTUAL)

February 4, 2016

Study Registration Dates

First Submitted

September 5, 2018

First Submitted That Met QC Criteria

September 7, 2018

First Posted (ACTUAL)

September 11, 2018

Study Record Updates

Last Update Posted (ACTUAL)

September 13, 2018

Last Update Submitted That Met QC Criteria

September 11, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • SOMS-GCS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

On reasonable request from researchers after an agreement has been found.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

Clinical Trials on Early, goal-directed mobilization

3
Subscribe